Traders sold shares of CVS Health Corporation (NYSE:CVS) on strength during trading hours on Monday. $46.89 million flowed into the stock on the tick-up and $104.72 million flowed out of the stock on the tick-down, for a money net flow of $57.83 million out of the stock. Of all stocks tracked, CVS Health Corporation had the 0th highest net out-flow for the day. CVS Health Corporation traded up $0.10 for the day and closed at $96.84

Several research firms have recently commented on CVS. Royal Bank Of Canada restated an “outperform” rating and set a $115.00 price target (up from $110.00) on shares of CVS Health Corporation in a research report on Wednesday, May 4th. Mizuho reiterated a “buy” rating and issued a $117.00 price objective (up from $104.00) on shares of CVS Health Corporation in a research note on Wednesday, May 4th. FBR & Co reiterated a “buy” rating on shares of CVS Health Corporation in a research note on Saturday, May 14th. Deutsche Bank AG increased their price objective on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research note on Wednesday, June 22nd. Finally, Leerink Swann reiterated a “buy” rating and issued a $110.00 price objective on shares of CVS Health Corporation in a research note on Thursday, May 5th. One analyst has rated the stock with a sell rating, four have given a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $113.72.

The stock’s 50 day moving average price is $95.76 and its 200-day moving average price is $98.37. The company has a market capitalization of $104.01 billion and a P/E ratio of 21.05.

CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, May 3rd. The pharmacy operator reported $1.18 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.02. The firm earned $43.20 billion during the quarter, compared to analysts’ expectations of $43.01 billion. During the same quarter last year, the company posted $1.14 EPS. The firm’s revenue was up 18.9% compared to the same quarter last year. Analysts anticipate that CVS Health Corporation will post $5.83 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, August 1st. Investors of record on Thursday, July 21st will be given a $0.425 dividend. The ex-dividend date of this dividend is Tuesday, July 19th. This represents a $1.70 annualized dividend and a dividend yield of 1.76%.

In other CVS Health Corporation news, EVP Troyen A. Brennan sold 7,517 shares of the stock in a transaction that occurred on Thursday, May 5th. The shares were sold at an average price of $105.00, for a total value of $789,285.00. Following the completion of the sale, the executive vice president now owns 69,601 shares in the company, valued at approximately $7,308,105. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Larry J. Merlo sold 38,247 shares of the stock in a transaction that occurred on Thursday, May 5th. The stock was sold at an average price of $105.00, for a total transaction of $4,015,935.00. Following the completion of the sale, the chief executive officer now owns 280,381 shares of the company’s stock, valued at approximately $29,440,005. The disclosure for this sale can be found here.

A number of large investors recently added to or reduced their stakes in CVS. Front Barnett Associates LLC increased its stake in CVS Health Corporation by 0.3% in the fourth quarter. Front Barnett Associates LLC now owns 49,762 shares of the pharmacy operator’s stock worth $4,865,000 after buying an additional 130 shares during the last quarter. ProVise Management Group LLC increased its stake in CVS Health Corporation by 0.5% in the fourth quarter. ProVise Management Group LLC now owns 28,448 shares of the pharmacy operator’s stock worth $2,782,000 after buying an additional 141 shares during the last quarter. Strategic Advisors LLC increased its stake in CVS Health Corporation by 1.5% in the fourth quarter. Strategic Advisors LLC now owns 10,401 shares of the pharmacy operator’s stock worth $1,017,000 after buying an additional 151 shares during the last quarter. NEXT Financial Group Inc increased its stake in CVS Health Corporation by 1.5% in the fourth quarter. NEXT Financial Group Inc now owns 10,611 shares of the pharmacy operator’s stock worth $1,037,000 after buying an additional 155 shares during the last quarter. Finally, WMS Partners LLC increased its stake in CVS Health Corporation by 1.4% in the fourth quarter. WMS Partners LLC now owns 11,098 shares of the pharmacy operator’s stock worth $1,085,000 after buying an additional 158 shares during the last quarter.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.